Filing Flows › Xtant Medical Holdings (XTNT) › Q2 2025
Xtant Medical Holdings (XTNT) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 12, 2025
Xtant Medical Holdings (XTNT) reported revenue of $35.4M for the second quarter 2025 (Q2 2025), +18% from a year earlier and +8% from the quarter before. Operating margin was 13.1%, net earnings $3.5M (10.0% of revenue).
Xtant Medical Holdings, Q2 2025: revenue $35.4M (+18% year over year), operating margin 13.1%, net earnings $3.5M, operating cash flow $1.3M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $35.4M | +8% | +18% |
| Gross profit | $24.3M | +20% | +31% |
| Operating profit | $4.6M | +335% | — |
| Net earnings | $3.5M | 61× | — |
| Operating cash flow | $1.3M | -0.2% | — |
| Free cash flow | $910K | +946% | — |
What changed
Revenue was $35.4M in Q2 2025, up 18% year over year and up 8% from the previous quarter. Orthobiologics was the largest line at 55% of revenue. Orthobiologics added $3.2M year over year (up 20%), 59% of the total change. Spinal Implant declined 20%.
Gross margin was 68.6%, up 6.5 points from a year earlier. Operating profit was $4.6M, a 13.1% margin (up 22.9 points year over year). Operating expenses fell 9% while revenue rose 18%. Net earnings were $3.5M. The effective tax rate was 6.7%.
Operating cash flow was $1.3M, 36% of net earnings. Non-cash charges added back $1.2M of depreciation and amortization and $800K of share-based compensation. Working capital and other items used $4.2M. Capital expenditures of $366K left free cash flow of $910K.
Questions
What was Xtant Medical Holdings' revenue in the second quarter 2025?
Xtant Medical Holdings (XTNT) reported revenue of $35.4M for the second quarter 2025 (Q2 2025), +18% from a year earlier and +8% from the quarter before.
Was Xtant Medical Holdings profitable in the second quarter 2025?
Operating profit was $4.6M (13.1% of revenue) and net earnings $3.5M.